THE endeavorRx video game was licensed last Tuesday, June 16 by the US Food and Drug Administration (FDA) as a functional treatment against attention deficit hyperactivity disorder (ADHD). The game is produced by Akili Interactive and has a traditional appearance; it consists of finishing missions in different scenarios, going through different obstacles.
Stay informed about what matters most to you
Get the most relevant news of the day in your email
Thank you for subscribing!
Check your inbox to confirm your email and start getting the latest news
Take advantage and take the next step
Get our news alerts so you don’t miss anything
Receive notifications
Enter your e-mail
Subscribe
Subscribing implies accepting the terms and conditions
You’re already subscribed to news alerts!
Now you can set up notifications from the bell
FDA clearance came after seven years of clinical trials in more than 600 children. The new digital therapy improves attention span for young people between the ages of eight and twelve with ADHD. You may be interested: Acetaminophen in pregnancy may increase the risk of ADHD and autismThe video game will be available only by prescription; the production company has already opened a waiting list on its website for interested parties to sign up.
One of several studies that have been conducted over the past seven years and culminated in EndeavorRx’s approval as a medical treatment found that one-third of children exposed to this therapy no longer had a significant attention deficit. Treatment involves playing 25 minutes a day, five days a week for a month. Studies alerted for possible side effects such as frustration and headaches.
What is ADHD?
ADHD is a common disorder that begins in childhood and affects approximately 4 million children in the U.S. ages 6 to 11. Symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and very high levels of activity. You might be interested: First time they authorize doctors to prescribe video games to kids with ADHD
